2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), a compound found in cooked meat, is a mammary gland carcinogen in rats. Comparative genomic hybridization of PhIP-induced rat mammary gland carcinomas revealed loss in the centromeric region of 2q, a region known to carry the mammary carcinoma susceptibility 1 (Mcs1) gene and several other genes relevant to carcinogenesis. Allelic imbalance, specifically microsatellite instability and loss of heterozygosity, was examined in mammary gland carcinomas induced by PhIP in Sprague-Dawley (SD) Â Wistar Furth F1 hybrid rats. In a polymerase chain reaction (PCR)-based assay with 34 microsatellite markers coinciding to 2q11-2q16, nine markers revealed allelic imbalance. The frequency of imbalance in the tumors varied from 10 to 100% depending on the specific marker. However, none of the markers coinciding with the Mcs1 gene locus showed allelic imbalance, suggesting that alterations at this locus were not associated with PhIPinduced rat mammary gland cancer. The expression of several genes physically mapped to 2q11-2q16 and potentially involved in carcinogenesis including Ccnb (cyclin B1), Ccnh (cyclin H), Rasa (Ras GAP), Rasgrf2, Pi3kr1 (p85a), and Il6st (gp130) was also examined by quantitative real-time PCR and immunohistochemistry (IHC) across a large bank of PhIP-induced SD rat mammary gland carcinomas. By quantitative real-time PCR, the mRNA expression of Rasa, Pi3kr1, Ccnh, and Il6st in carcinomas was, respectively, 22-, 20-, three-and threefold higher in carcinomas than in control mammary gland tissues (Po0.05, Student's t-test). A statistically sixfold lower expression of Rasgrf 2 was detected in carcinomas whereas no significant change in Ccnb1 expression was observed. The findings from quantitative real-time PCR were confirmed by IHC for each gene. In addition, the proliferation index in mammary gland carcinomas as assessed by PCNA was found to correlate with the overexpression of Cyclin H by IHC analysis (Po0.05, Spearman Rank Order Correlation). The findings from the current study implicate molecular alterations in the proximal region of 2q in PhIP-induced rat mammary gland carcinomas.
2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP), a compound found in cooked meat, is a mammary gland carcinogen in rats. Comparative genomic hybridization of PhIP-induced rat mammary gland carcinomas revealed loss in the centromeric region of 2q, a region known to carry the mammary carcinoma susceptibility 1 (Mcs1) gene and several other genes relevant to carcinogenesis. Allelic imbalance, specifically microsatellite instability and loss of heterozygosity, was examined in mammary gland carcinomas induced by PhIP in Sprague-Dawley (SD) Â Wistar Furth F1 hybrid rats. In a polymerase chain reaction (PCR)-based assay with 34 microsatellite markers coinciding to 2q11-2q16, nine markers revealed allelic imbalance. The frequency of imbalance in the tumors varied from 10 to 100% depending on the specific marker. However, none of the markers coinciding with the Mcs1 gene locus showed allelic imbalance, suggesting that alterations at this locus were not associated with PhIPinduced rat mammary gland cancer. The expression of several genes physically mapped to 2q11-2q16 and potentially involved in carcinogenesis including Ccnb (cyclin B1), Ccnh (cyclin H), Rasa (Ras GAP), Rasgrf2, Pi3kr1 (p85a), and Il6st (gp130) was also examined by quantitative real-time PCR and immunohistochemistry (IHC) across a large bank of PhIP-induced SD rat mammary gland carcinomas. By quantitative real-time PCR, the mRNA expression of Rasa, Pi3kr1, Ccnh, and Il6st in carcinomas was, respectively, 22-, 20-, three-and threefold higher in carcinomas than in control mammary gland tissues (Po0.05, Student's t-test). A statistically sixfold lower expression of Rasgrf 2 was detected in carcinomas whereas no significant change in Ccnb1 expression was observed. The findings from quantitative real-time PCR were confirmed by IHC for each gene. In addition, the proliferation index in mammary gland carcinomas as assessed by PCNA was found to correlate with the overexpression of Cyclin H by IHC analysis (Po0.05, Spearman Rank Order Correlation). The findings from the current study implicate molecular alterations in the proximal region of 2q in PhIP-induced rat mammary gland carcinomas. Oncogene (2003 Oncogene ( ) 22, 1253 Oncogene ( -1260 Oncogene ( . doi:10.1038 Keywords: heterocyclic amines; allelic imbalance; quantitative real-time polymerase chain reaction; microsatellite instability; loss of heterozygosity; gene expression; rat chromosome 2q Introduction 2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) is a mutagen/carcinogen present in the human diet in cooked meat. PhIP is a mammary gland carcinogen in rats and a suspected human mammary gland carcinogen (Layton et al., 1995; Sinha et al., 2000; Snyderwine, 2000) . Multiple oral doses of PhIP induce approximately a 50% incidence of mammary gland carcinoma in female Sprague-Dawley (SD) rats (Ghoshal et al., 1994; Snyderwine et al., 1998) .
Chemical carcinogen-induced rat mammary gland carcinogenesis provides a valuable model for investigating the processes involved in disease development including molecular alterations (Russo et al., 1990) . Multiple molecular alterations have been reported in PhIP-induced mammary gland carcinomas (Snyderwine, 2000) . These alterations include mutations in the H-ras gene, allelic imbalance including loss of heterozygosity (LOH) and microsatellite instability (MSI) throughout the 21 rat chromosomes, changes in expression of various genes as detected by cDNA microarray analysis, and an increase in the spontaneous mutation rate in tumor-derived cell lines (Toyota et al., 1996; RobertsThomson and Snyderwine, 1997; Hokaiwado et al., 2001; Watanabe et al., 2001; Yu et al., 2000; Shan et al., 2002; Yu and Snyderwine, 2002) . A recent study using comparative genomic hybridization (CGH) has revealed a consistent pattern of chromosomal aberration in PhIPinduced carcinomas including loss in the regions of chromosomes 2q, 3p, 11p, 18p, and X (Christian et al., 2002) . This finding raises the possibility that critical genes involved in mammary gland carcinogenesis are harbored in these regions.
As a starting point for the analysis of genes in these deleted regions, the current study focused on the molecular alterations in chromosome 2q11-2q16 in PhIP-induced rat mammary gland carcinomas. The centromeric region of rat chromosome 2q contains multiple genes potentially involved in mammary gland carcinogenesis such as the mammary gland cancer susceptibility 1 (Mcs1) gene (Hsu et al., 1994; Haag et al., 1996; Shepel et al., 1998; Szpirer et al., 1999; Quan et al., 2000; Laes et al., 2001 ) (http://ratmap.gen.gu.se/) (Figure 1 ). Mcs1 is one of the several mammary gland cancer susceptibility genes that modify the susceptibility of rats to chemical and radiation-induced mammary carcinogenesis (Shepel et al., 1998) . Six of six PhIPinduced mammary carcinomas examined by CGH analysis show under-representation in the centromeric region of 2q, and therefore possibly involving the Mcs1 gene locus (Christian et al., 2002) . Multiple microsatellite markers are currently available to examine this region for allelic imbalance in more detail (http:// ratmap.gen.gu.se/) (Szpirer et al., 1999; Quan et al., 2000; Laes et al., 2001) . Several of the known genes mapped in this region include genes that regulate the activity of Ras including Rasa (Ras GTP-ase activating protein, Ras-GAP) and Rasgrf2 (Ras guanine nucleotide exchange factor 2). The high frequency of H-ras mutations in PhIP-induced carcinomas raises the possibility that these genes that regulate Ras activity might also be affected during carcinogenesis. In addition, this region harbors Pi3kr1, the p85a subunit of phosphatidylinositol 3-kinase (PI3K), a gene known to cooperate with H-Ras in cellular transformation (Rodriguez-Viciana et al., 1997; Rodriguez-Viciana and Downward, 2001 ). Other genes in this region include Ccnb1 and Ccnh, as well as Il6st (gp130), a cytokine receptor modulator, all potentially implicated in carcinogenesis and/or mammary gland carcinogenesis (Szpirer et al., 1999; Laes et al., 2001) . With the purpose of obtaining a view to the involvement of genes in the frequently deleted region of chromosome 2q, the current study examines 2q11-2q16 for allelic imbalance with microsatellite markers, and evaluates the expression of known cancer-regulating genes residing in this region by quantitative real-time polymerase chain reaction (PCR) and immunohistochemistry (IHC).
Results
A total of 34 polymorphic microsatellite markers coinciding with the proximal region of 2q (some of which have been physically mapped, but the majority localized by linkage mapping only) were used to examine allelic imbalance in PhIP-induced mammary gland carcinomas in SD Â Wistar Furth F1 hybrid rats. Nine markers revealed LOH and/or MSI (Table 1) . Samples showing LOH had a loss of one allele, whereas MSI was apparent when allele size was altered (Figure 2 ). Of the 11 carcinomas examined from F1 rats, the frequency of allelic imbalance ranged from 1/11 (9%) at D2Rat6 to 11/11 (100%) in D2Rat9. Several markers (D2Rat188, D2Rat182, D2Rat253, D2Rat9, Figure 1 Partial physical map of rat chromosome 2. The approximate region of under-representation found by CGH analysis of PhIP-induced rat mammary gland carcinomas is from Christian et al. (2002) . The approximate location of several physically mapped genes and microsatellite markers is from http://ratmap.gen.gu.se as refined according to Laes et al. (2001) and Quan et al. (2000) Position from SHRSP Â BN or FHH Â ACI of genetic map (http://rgd.mcw.edu/). N/A, not available. Linkage mapping suggests D2Ulb1 is proximal to D2Rat182 (Quan et al., 2000) Additional markers examined in rats that showed no differences between carcinomas and normal tissues included: D2Rat1, D2Rat2, D2Rat3, D2Rat4, D2Rat5, D2Rat7, D2Rat10, D2Rat73, D2Rat116, D2Rat187, D2Rat191, D2Rat192, D2Rat194, D2Rat195, D2Rat251, D2Rat252, D2Rat307, D2Rat310, D2Ulb24, D2Ulb25, D2Ulb28, D2Ulb33, D2Wox2, D2Mit1, D2Mit29 and D2Ulb1) showed both MSI and LOH depending on the tumor sample. The frequency of MSI was over twofold higher than the frequency of LOH. None of the known markers for the Mcs1 locus showed LOH including D2Rat1, D2Rat2, D2Rat3, D2Rat307, D2Mit1, D2Mit29, D2Ulb24, D2Ulb25, and D2Ulb28.
Quantitative real-time PCR was further used to examine the mRNA expression of six genes physically mapped to 2q11-2q16 (Table 2) . Four genes showed statistically higher expression in carcinomas than in normal mammary glands: Rasa, Pi3kr1, Ccnh, and Il6st (Student's t-test, Po0.05). Rasa showed the highest expression relative to normal mammary gland followed by Pi3kr1 (22-and 20-fold higher than normal tissue, respectively). Rasgrf2, in contrast, showed a statistically lower relative expression in carcinomas. The expression of Rasgrf2 in carcinomas was 17% the level in the normal mammary gland. The expression of Ccnb1, a putative candidate for the Mcs1 gene (Szpirer et al., 1999) , was not significantly altered between carcinoma and normal tissue.
The mRNA expression of the six genes examined by quantitative real-time PCR was also evaluated by immunohistochemical staining of carcinomas and normal tissues from SD rats (Figure 3 ). Immunohistochemical analysis indicated that Cyclin B1 and Cyclin H protein expression were nuclear, whereas IL6st gp130 and Pi3k p85a were expressed in the cytoplasm ( Figure  3a -h). Unexpectedly, Ras GAP and Rasgrf2 protein staining was largely nuclear rather than cytoplasmic (Figure 3i -l). The percentage of positively stained cells revealed with each antibody was calculated for normal glands and carcinomas. In accordance with the findings from quantitative real-time PCR analysis, IHC indicated a statistically significantly higher protein expression for Cyclin H, IL6st gp130, Pi3k p85a, and Ras GAP in carcinomas versus normal glands (Student's ttest, Po0.05) (Figure 4 ). In addition, carcinomas showed a significantly lower protein expression of Rasgrf2 in comparison with normal tissues. However, the expression of Cyclin B1 protein was not significantly different between carcinomas and normal mammary glands. Carcinomas showed greater than a threefold higher nuclear expression of PCNA than did normal mammary glands, a difference that was statistically significant (Student's t-test, Po0.05). Spearman Rank Order Correlation analysis was carried out to determine whether expression of PCNA, a measure of cellular proliferation, correlated with the expression of any of the six genes altered in PhIP-induced carcinomas. A statistically significant positive correlation was observed between PCNA and Cyclin H protein expression (correlation coefficient, 0.474, Po0.05, N ¼ 51).
Discussion
CGH analysis indicated that a high percentage of PhIPinduced rat mammary gland carcinomas showed underrepresentation in the proximal region of 2q (Christian et al., 2002 ). In the current study, the findings from the microsatellite analysis support the notion that PhIPinduced rat mammary gland carcinomas showed allelic imbalance in chromosome 2q. Out of the 34 markers examined, nine markers residing by linkage analysis in the centromeric region of 2q showed allelic imbalance involving MSI and/or LOH. Of the markers showing allelic imbalance, D2Rat188 and D2Rat189 are by linkage mapping most proximally located (Laes et al., 2001) . Approximately, 50% of carcinomas showed allelic imbalance at these markers. D2Rat9, which appears to be more distally located by linkage mapping, showed an allelic imbalance frequency of 100% among the tumors examined. Although it was anticipated from CGH analysis that the most proximal markers would show the highest frequency of LOH, it is possible that inherent difficulties in LOH analysis (Tomlinson et al., 2002) , the relative paucity of physically mapped markers, and the low resolution capacity of CGH analysis (approximately 10-15 megabases) may have obscured a clear concordance between CGH and LOH analysis. Nevertheless, the finding that many of the markers located in 2q showed allelic imbalance suggests the involvement of this chromosomal region in PhIPinduced rat mammary gland carcinogenesis.
The Mcs1 gene has been shown to reside in the proximal 2q and the current study examined whether Chromosome 2q alterations in PhIP-induced rat mammary gland carcinomas C Qiu et al genomic alterations in the Mcs1 gene locus were involved in PhIP-induced rat mammary gland cancer. Microsatellite markers known to reside in the Mcs1 locus including D2Ulb24, U2Ulb25, D2Ulb28, D2Mit29, D2Rat2, R2Rat3, D2Rat1, D2Rat307, and D2Mit1 were used to examine allelic imbalance in PhIPinduced rat mammary gland carcinomas in F1 rats (Shepel et al., 1998; Szpirer et al., 1999; Laes et al., 2001) . However, none of the markers revealed either MSI or LOH. In accordance with these findings, a previous study reported no LOH in the Mcs1 gene locus in 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinomas in Wistar Furth Â Copenhagen F1 rats (Haag et al., 1996) . Through cytogenetic analysis, Ccnb1 has been proposed as a possible candidate for the Mcs1 gene (Szpirer et al., 1999) . However, no LOH was detected at D2Ulb33, a microsatellite marker in the Ccnb1 locus. In addition, no significant change in the expression of Ccnb1 in carcinomas was observed by quantitative real-time PCR analysis. Therefore, LOH in the Mcs1 gene does not appear to be a feature of PhIPinduced mammary gland cancer, at least not in this rat model. In addition to Ccnb1, the expression of five other genes (Ccnh, Il6st, Pi3kr1, Rasa, Rasgrf2) residing in 2q11-2q16 was examined by quantitative real-time PCR and IHC to provide further insight into the molecular alterations involved in PhIP-induced rat mammary gland carcinogenesis. By quantitative real-time PCR, the mRNA expression in carcinomas relative to normal tissues was shown to be significantly higher for Ccnh, Il6st, PI3kr1, Rasa and significantly lower for Rasgrf2. Changes in protein expression as detected by IHC, in general, paralleled the change in mRNA expression as detected by quantitative real-time PCR. Therefore, the expression of many of the genes that reside in 2q11-2q16 was altered in PhIP-induced rat mammary gland carcinomas; however, the mechanisms accounting for the altered expression are still unknown. It is tempting to speculate that the allelic imbalance in chromosome 2q Figure 3 Immunohistochemical analysis of normal rat mammary gland and PhIP-induced rat mammary gland carcinomas. Immunostaining for Cyclin B1 (a, b), Cyclin H (c, d), IL6st (gp130) (e, f), PI3K (p85a) (g, h), Ras GAP (i, j), Rasgrf2 (k, l), PCNA (m, n) in normal and carcinomas, respectively. H&E staining of normal and carcinoma (o, p). Magnification, Â 400
Chromosome 2q alterations in PhIP-induced rat mammary gland carcinomas C Qiu et al was partly responsible for changes in gene expression, especially with regard to LOH and reduced expression of Rasgrf2. Rasgrf2 and Rasa are involved in controlling the Ras oncogene GTPase activity with opposing actions (Boguski and McCormick, 1993; Lowy and Willumsen, 1993) . Rasa, also known as rasGTPase-activating protein, Ras GAP, downregulates activated Ras by converting GTP-bound Ras to GDP-bound Ras. Rasgrf2, a widely expressed guanine nucleotide exchange factor, promotes the release of bound GDP facilitating GTP binding and Ras activation. PhIP-induced rat mammary gland carcinomas are known to harbor H-ras mutations indicating that activation of the H-Ras pathway plays a role in these carcinomas (RobertsThomson and Snyderwine, 1997; Hokaiwado et al., 2001; Yu and Snyderwine, 2002) . However, the observed changes in the expression of Rasa and Rasgrf2 were contrary to the changes expected if the H-Ras pathway were activated. Specifically, we observed an increased expression of Rasa and a decreased expression of Rasgrf2. The net effect of these changes would be a reduction in H-Ras activity. However, by IHC, we found that the differences in protein expression between carcinomas and controls for both Ras GAP and Rasgrf2 were largely because of changes in the nuclear expression of these proteins. Therefore, changes in the expression of these genes may have less relevance to the activity of H-Ras than to other effects on the cell. Ras GAP protein overexpression has been previously associated with basal cell carcinoma and prostate cancer Davidson et al., 1998) . Recent studies of prostate cancer have suggested that Ras GAP expression is nuclear in a percentage of prostate tumors, and may play a role in prostate cell proliferation . Interestingly, it has been reported that Ras GAP generates potent antiapoptotic signals after cleavage by caspase and may play an antiapoptotic role in tumor cell lines (Leblanc et al., 1999; Yang and Widmann, 2002) . It is tempting to speculate that the elevated Ras GAP may provide an antiapoptotic function in PhIP-induced rat mammary gland carcinomas. The changes in nuclear expression of Rasgrf2 also raise the possibility that the reduced expression of this gene has consequences other than modulation of H-Ras activity. Although Rasgrf2 expression has been shown to be nuclear in adult mouse brain (Fernandez-Medarde et al., 2002) , little is known about the role of nuclear Rasgrf2 expression during carcinogenesis.
Several other genes were also shown to have altered expression in PhIP-induced carcinomas. Pi3kr1, the p85alpha regulatory subunit of PI3K, was overexpressed in PhIP-induced rat mammary gland carcinomas. Activation of PI3K pathway has been recognized to be involved in human breast cancers (Gershtein et al., 1999; Mills et al., 2001) , and the findings from the current study support the involvement of this pathway in PhIP-induced rat mammary gland cancer. It is also notable that PI3K is a major pathway mediating Rasdependent signaling (Rodriguez-Viciana et al., 1996) . In addition, Ras activation of PI3K is important for the survival of transformed cells and an essential antiapoptotic effector in the proliferative response of mammary epithelial cells to mutant ras (Rodriguez-Viciana et al., 1997; Gire et al., 2000) . Since H-ras activating mutations are found in PhIP-induced rat mammary gland carcinomas, it appears possible that Ras activation of the PI3K pathway occurs in PhIP-induced rat mammary gland carcinomas.
Additional genes showing altered expression in these carcinomas were Il6st and Ccnh. The Il6st component gp130 is used in common for several cytokines, such as oncostatin M, a cytokine regulating the growth of normal and malignant mammary epithelial cells (Crichton et al., 1996; Liu et al., 1998; Grant et al., 2001) . Cyclin H is a regulatory component of the cyclindependent kinase-activating kinase and part of the transcription factor IIH (TFII), a factor known to affect DNA repair and p53 function (Ko et al., 1997; Schultz et al., 2000) . A recent study reported reduced expression of Cyclin H in human prostate cancer cells (Karan et al., 2002) . In rat mammary gland carcinomas, however, Ccnh expression was elevated over threefold on average. In addition, IHC analysis of carcinomas revealed that Cyclin H overexpression was positively correlated with proliferation as measured by PCNA staining. Further studies are warranted to investigate the impact of altered Ccnh expression in mammary gland carcinogenesis.
The findings from this study implicate many of the altered genes residing in the proximal region of chromosome 2 in PhIP-induced rat mammary gland carcinogenesis. The results from MSI analysis confirm that PhIP-induced rat mammary gland carcinomas harbor alterations in the centromeric region of chromosome 2. Although the majority of known genes in 2q showed overexpression, further studies are required to determine if Rasgrf2, a gene regulating the activity of Ras, coincides with the region of under-representation previously observed by CGH. Rat chromosome 2q11-2q16 is homologous to human chromosome 5q11-5q14 Chromosome 2q alterations in PhIP-induced rat mammary gland carcinomas C Qiu et al (http://rgd.mcw.edu/). Interestingly, human breast carcinomas show LOH in this region (Kerangueven et al., 1997) , suggesting that further study of the involvement of the genes in this region in human breast cancer may be warranted. Investigation of the genomic alterations in 2q11-2q16 in the rat model and the associated changes in cell signaling pathways are also expected to provide insight into the genomic alterations associated with human breast cancer.
Materials and methods

Rat mammary gland carcinomas and normal tissues
PhIP-induced mammary gland carcinomas and control mammary gland samples from female SD rats that were used in the current study were from archival tissue samples that were stored frozen at À801C and as formalin-fixed paraffinembedded blocks at 41C. SD Â Wistar Furth F1 hybrid rats were bred and treated with PhIP (75 mg/kg, per os, 10 doses, once per day for 10 days) and placed on a high fat diet (23.5% corn oil) using the protocol described previously for SD rats (Ghoshal et al., 1994; Snyderwine et al., 1998) . For breeding, female SD rats were obtained from the NIH animal supply (Animal Production Area, FCRDC, Frederick, MD, USA) and male Wistar Furth rats obtained from Harlan Teklad (Madison, WI, USA). Animals were housed in an AALAC accredited facility and maintained in accordance with the procedures outlined in the Guide for Care and Use of Laboratory Animals. PhIP-induced mammary gland tumor incidence in female F1 hybrid rats was 22% within 45 weeks of dosing. Tumors and surrounding normal tissue were stored frozen at À801C and in formalin-fixed paraffin-embedded blocks at 41C until use. Only tubulopapillary carcinomas, the major type of tumor found in SD rats and the F1 hybrids, were used in the current study.
DNA and RNA isolation
For analysis of LOH and MSI, DNA was isolated from frozen tissue by phenol-chloroform extraction. Briefly, samples were homogenized in lysis buffer (10 mm Tris-HCl and 1 mm EDTA), the homogenate was incubated with RNAse for 3-4 h at 371C. This was followed by an overnight incubation with proteinase K (100 mg/ml) in the presence of 1% sodium dodecyl sulfate. After phenol-chloroform extraction, DNA was precipitated with 95% ethanol, washed in 70% ethanol, and suspended in TE buffer. For quantitative real-time PCR analysis, total RNA was isolated using TRIzol extraction reagent (GIBCO BRL, Rockville, MD, USA) according to the protocol provided by the company. The RNA was aliquoted and stored at À801C until use. Each aliquot was thawed only once and used immediately.
LOH and MSI analysis using polymorphic microsatellite markers LOH and MSI analysis was carried out by a PCR-based assay essentially as described previously (Yu et al., 2000) . Primers to 34 polymorphic microsatellite markers were obtained from Operon (Alameda, CA, USA) according to sequences provided at http://www-genome.wi.mit.edu/ and by Szpirer and colleagues (Laes et al., 2001; Quan et al., 2000; Szpirer et al., 1999) . The PCR reaction consisted of DNA template, 1 ml (10 ng), TakaRa EX Taq DNA polymerase (Takara Shuzo Co. LTD, Japan), [
33 P] dATP, 0.1 ml (ICN, Costa Mesa, CA, USA specific activity 3000 mci/mmol, 10 mCi/ml), and PCR master mix to a total volume of 10 ml. PCR was carried out in GeneAmp PCR System 9700 (Perkin-Elmer Cetus, Norwalk, CT, USA) at 941C for 3 min, followed by 30 cycles of 941C for 30 s, 551C for 30 s, 721C for 45 s, and 721C for 7 min for extension. After PCR amplification, 10 ml loading buffer was added and heated at 941C for 3 min. Samples were loaded onto CastAway 8% Precast Polyacrylamide Gels (Stratagene, Cedar Creek, TX, USA) and electrophoresed at 1500 V for 2 h. After drying the gels, bands were visualized by autoradiography. Band intensities were quantified by ImageQuant Software (version3.3). LOH was defined as 50% or greater reduction in electrophoresis band intensity in tumor compared with that in the normal tissue, and MSI instability was defined as any change in allele size.
Quantitative real-time PCR analysis
The relative quantitation of gene expression was determined by quantitative real-time PCR analysis with the ABI Prism 7900 Sequence Detection System (PE Applied Biosystems, Foster City, CA, USA) using the comparative method. RNA isolated as described above was treated with DNA-freet (Ambion, Inc. Austin, TX, USA) prior to reverse transcription to avoid genomic DNA contamination. Reverse transcription was carried out with ThermoScriptt RT-PCR System (Invitrogen, Carlsbad, CA, USA) using OligoDT20. Conditions for quantitative real-time PCR analysis were first optimized with cDNA from the rat NMU mammary carcinoma cell line (ATCC, Manassas, VA, USA). Standard curves were generated with various amounts of cDNA (10-3000 ng) from the NMU cell line. Reactions were also routinely run without template as a negative control. Primers and probes for the quantitative real-time PCR analysis were designed using Primer Express Software V. 2.0 (Applied Biosystems, Foster City, CA, USA) (Table 3) . Quantitative real-time PCR products were approximately in the range of 50-150 base pairs in length. The TaqMan rodent GAPDH set (Applied Biosystems, Foster City, CA, USA) was used as the reference control for normalization of the target genes. GAPDH was chosen as the reference because it was consistently and 
Chromosome 2q alterations in PhIP-induced rat mammary gland carcinomas C Qiu et al reproducibly expressed in all samples. To ensure the quality of all the primers, quantitative real-time PCR amplification was first carried out with SYBR s Green PCR core reagent (AppliedBiosystems, Foster City, CA, USA), the dissociation curves were examined to confirm that no nonspecific bands arose with the primers. Subsequently, amplifications were carried out with TaqMan s PCR Core Reagent, primers, and the dual fluorescence-labeled probe (5 0 6-FAM and 3 0 TAMRA). The reaction conditions for quantitative real-time PCR were 10 Â TaqMan Buffer 5 ml, 25 mm MgCl 2 11 ml, 10 mm dATP 1 ml, 10 mm dCTP 1 ml, 10 mm dGTP 1 ml, 20 mm dUTP 1 ml, 10 mm forward primer 1 ml, 10 mm reverse primer 1 ml, 5 mm probe 1 ml, Amp Erase UNG 0.5 ml, AmpliTaq Gold DNA polymerase 0.25 ml, water 25.25 ml, cDNA 1 ml, in a total volume of 50 ml. Each sample was run in duplicate in separate wells for the target gene and rodent GAPDH. The quantitative real-time PCR amplification conditions were 501C for 2 min, 951C for 10 min, followed by 50 cycles of 951C for 15 s and 601C for 1 min. The threshold cycles (C T ) were recorded for all samples for both the target gene and the reference. Relative gene expression was derived by the method outlined in ABI Prism Sequence Detection System User Bulletin #2 from the following formulas: For statistical analysis, Student's t-test compared DC T of the tumor to the DC T of the control tissue. The range for the relative expression was derived from the s.e. of the DC T values and calculated as the exponential function of ÀDDC T +s.e.m. and ÀDDC T À s.e.m.
Immunohistochemical assay
Primary antibodies for Cyclin H (sc-1662), IL6st gp130 (SC-656), PI3-kinase p85a(Z-8), Ras GAP (sc-63), and Ras-GRF2 (sc-7591) were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA). Cyclin B1 (M3530) and proliferating cell nuclear antigen (PCNA, M0879) was obtained from DAKO (Carpinteria, CA, USA). IHC staining was carried out using the Universal DAKO LSAB2 System. Briefly, 5 mm tissue sections were deparaffinized and rehydrated in xylene and ethanol. Antigen retrieval was performed by immersing the slides in 0.01 m citric acid buffer (pH 6.0) and microwaving. The endogenous peroxidase activity was blocked by incubation with 0.25% hydrogen peroxide in methanol. The slides were incubated sequentially with primary antibodies overnight at 41C and then with HRP-labeled secondary antibodies for 2 h at room temperature. Negative controls were run without the primary antibody incubation. Sections were developed using AEC substrate and counterstained with Mayer's hematoxylin. For quantitation of stained cells, 1000 cells in four high-power fields ( Â 400) were counted. Cells with either brown-colored nuclei or cytoplasmic staining were scored as positive and the percentage of stained cells calculated.
Statistical analysis
Statistical analysis including Student's t-test (one or two tail) and Spearman Rank Order Correlation was carried out which were indicated using SigmaStat Statistical Software, version 2.0 (Jandel, San Rafael CA, USA). Statistical significance was assumed at Po0.05.
